|
Market Closed -
Australian S.E.
00:55:18 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.7150 AUD | -4.67% |
|
-12.27% | -26.29% |
| 08-28 | OncoSil Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-27 | OncoSil Medical Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 26.24M 18.47M 16.58M 15.32M 13.88M 25.93M 1.76B 183M 72.98M 921M 69.33M 67.86M 2.92B | P/E 2027 * |
-0.02x | P/E 2028 * | -0.04x |
|---|---|---|---|---|---|
| Enterprise Value | 26.24M 18.47M 16.58M 15.32M 13.88M 25.93M 1.76B 183M 72.98M 921M 69.33M 67.86M 2.92B | EV / Sales 2027 * |
4.45x | EV / Sales 2028 * | 2.76x |
| Free-Float |
90.14% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: OncoSil Medical Limited
| 1 day | -4.67% | ||
| 1 week | -12.27% | ||
| Current month | -17.34% | ||
| 1 month | -15.88% | ||
| 3 months | -38.89% | ||
| 6 months | +47.42% | ||
| Current year | -26.29% |
| 1 week | 0.7 |  | 0.8 |
| 1 month | 0.68 | | 0.88 |
| Current year | 0.37 | | 1.64 |
| 1 year | 0.37 | | 1.64 |
| 3 years | 0.37 | | 6 |
| 5 years | 0.37 | | 32.4 |
| 10 years | 0.37 | | 102 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nigel Lange
CEO | Chief Executive Officer | - | 2021-01-20 |
Shelley Steyn
DFI | Director of Finance/CFO | - | 2025-05-04 |
Jon Bell
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Nigel Lange
BRD | Director/Board Member | - | 2021-01-20 |
Lel Smits
BRD | Director/Board Member | - | 2025-01-14 |
Thomas Duthy
CHM | Chairman | - | 2025-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/20/21 | Free | Chief Executive Officer | 2,841,633 | 0.3586% | ||
| 8/24/21 | Buy | Director | 95,000 | 0.0119% | ||
| 5/10/21 | Sell | Chairman | 10,000,000 | 1.2386% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.67% | -12.27% | -52.33% | -80.14% | 19.36M | |
| +0.50% | +1.38% | +57.09% | +127.73% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +84.34% | 647B | |
| -0.14% | +0.42% | +25.69% | +101.56% | 506B | |
| -0.05% | +2.28% | +49.14% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.25% | 350B | |
| +0.34% | +2.15% | +25.26% | +54.27% | 293B | |
| -0.45% | +1.16% | +1.74% | +26.08% | 265B | |
| +0.87% | +3.08% | +54.69% | +71.67% | 242B | |
| +0.08% | +3.67% | +35.05% | +104.71% | 197B | |
| Average | -0.13% | -0.04% | +30.33% | +59.52% | 402.76B | |
| Weighted average by Cap. | +0.59% | +0.71% | +43.68% | +87.35% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 5.9M 4.15M 3.73M 3.45M 3.12M 5.83M 396M 41.19M 16.41M 207M 15.59M 15.26M 657M | 9.5M 6.69M 6M 5.55M 5.02M 9.39M 637M 66.33M 26.42M 333M 25.1M 24.57M 1.06B |
| Net income | -9.6M -6.76M -6.06M -5.61M -5.08M -9.49M -644M -67.03M -26.7M -337M -25.36M -24.83M -1.07B | -5.7M -4.01M -3.6M -3.33M -3.01M -5.63M -382M -39.8M -15.85M -200M -15.06M -14.74M -635M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | A$0.7150 | -4.67% | 23,117 |
| 26-10-27 | A$0.7500 | +7.14% | 14,682 |
| 26-10-26 | A$0.7000 | -2.78% | 22,213 |
| 26-10-23 | A$0.7200 | -8.86% | 56,688 |
| 26-10-22 | A$0.7900 | -1.25% | 13,646 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7150
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OSL Stock
Select your edition
All financial news and data tailored to specific country editions
